Bharat Parenterals Ltd.
•Market Cap₹ 1,069 Cr.
Current Price
High / Low₹ 1,649 / 1,126
Stock P/E—
Book Value₹ 462
Price to Book2.06
Dividend Yield0.06 %
ROCE-4.9 %
ROE-16.5 %
Face Value₹ 10
Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
Confidence
View full sector analysis →50%
PROS
CONS
- Company is loss-making at the operating / net level
- Operating cash flow has been negative in recent years
- Company has a low return on equity of -0.7% over last 3 years
- Company has a low return on capital employed of 5.2%
- Promoter holding has decreased over last 2 years: -6.1pp
- Interest coverage is weak at -1.6x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | 1933.00 | 38.34 | 463791.45 | 0.83 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| DIVISLAB | 9232.00 | 83.79 | 245080.59 | 0.33 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| TORNTPHARM | 5004.40 | 87.28 | 190351.29 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| ZYDUSLIFE | 1151.20 | 25.44 | 114832.64 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| CIPLA | 1413.15 | 33.87 | 114162.52 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| LAURUSLABS | 1863.00 | 92.06 | 100660.17 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| LUPIN | 2152.60 | 17.80 | 98431.05 | 0.84 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| MANKIND | 2380.00 | 48.13 | 98304.73 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| DRREDDY | 1161.00 | 30.07 | 96906.34 | 0.69 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| AUROPHARMA | 1656.30 | 25.67 | 95299.84 | 0.24 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| GLENMARK | 2451.70 | 38.49 | 69193.02 | 0.10 | 482.83 | 927.88 | 4018.48 | 31.35 | 20.35 | 20.03 |
| BPLPHARMA | 1551.25 | 110.48 | 1069.12 | 0.06 | -3.56 | -309.54 | 93.74 | -19.19 | -4.85 | 9.11 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70 | 60 | 60 | 68 | 93 | 72 | 72 | 104 | 116 | 65 | 65 | 100 | 94 | |
| 59 | 55 | 53 | 67 | 88 | 79 | 69 | 102 | 102 | 64 | 63 | 100 | 96 | |
| Operating Profit | 10 | 4 | 7 | 1 | 4 | -8 | 4 | 2 | 14 | 1 | 2 | -1 | 9 |
| OPM % | 14.95% | 7.24% | 11.05% | 1.47% | 4.85% | -10.68% | 5.05% | 2.14% | 11.88% | 1.28% | 2.68% | -0.52% | 9.11% |
| Other Income | 2 | 3 | 1 | 3 | 3 | 4 | 3 | 2 | 1 | 4 | 1 | 4 | 1 |
| Interest | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 2 |
| Depreciation | 2 | 2 | 2 | 4 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 |
| 10 | 5 | 5 | -1 | -5 | -15 | -6 | -8 | 3 | -7 | -8 | -8 | -1 | |
| Tax % | 30.46% | 46.48% | 33.46% | -88.24% | -85.32% | -13.99% | -43.09% | -13.73% | 134.12% | -17.65% | -16.79% | 2.51% | -138.65% |
| Net Profit | 0 | 0 | 0 | 0 | -9 | -18 | -8 | -9 | -1 | -9 | -10 | -8 | -4 |
| 13 | 6 | 6 | -1 | -15 | -27 | -11 | -14 | -1 | -14 | -14 | -12 | -1 | |
| Equity Capital | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 124 | 111 | 137 | 220 | 228 | 205 | 212 | 218 | 261 | 340 | 323 | |
| 114 | 105 | 124 | 191 | 201 | 179 | 184 | 198 | 234 | 338 | 324 | |
| Operating Profit | 15 | 14 | 19 | 42 | 40 | 34 | 36 | 32 | 32 | 14 | — |
| OPM % | 12 | 13 | 14 | 19 | 17 | 17 | 17 | 15 | 12 | 4 | — |
| Other Income | 5 | 8 | 7 | 13 | 12 | 9 | 8 | 12 | 5 | 12 | 10 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 13 | 11 |
| Depreciation | 4 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 9 | 35 | 34 |
| 9 | 7 | 13 | 35 | 33 | 27 | 28 | 24 | 19 | -34 | -25 | |
| Tax % | 31 | 8 | 29 | 39 | 26 | 25 | 25 | 33 | 44 | -29 | -18 |
| Net Profit | 6 | 7 | 9 | 21 | 24 | 20 | 21 | 16 | 11 | -44 | -30 |
| EPS | 0 | 0 | 0 | 0 | 42 | 36 | 37 | 28 | 25 | -18 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 4 | -5 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 31 | -5 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 11 | 12 | 16 | 37 | 42 | 36 | 36 | 28 | 25 | -18 | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 8%
- 3 Years:
- 17%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- 11%
- 5 Years:
- 5%
- 3 Years:
- -1%
- Last Year:
- -17%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 |
| 51 | 58 | 67 | 88 | 112 | 138 | 160 | 176 | 191 | 324 | |
| 13 | 0 | 5 | 2 | 0 | 1 | 3 | 36 | 81 | 100 | |
| Trade Payables | 39 | 36 | 27 | 32 | 43 | 26 | 24 | 51 | 59 | 74 |
| 12 | 10 | 26 | 31 | 27 | 28 | 34 | 81 | 166 | 153 | |
| Total Liabilities | 120 | 110 | 130 | 159 | 187 | 199 | 226 | 350 | 504 | 658 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 35 | 31 | 34 | 34 | 32 | 43 | 40 | 41 | 210 | 251 | |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 12 | 0 | 26 | 99 | 24 | 30 |
| 0 | 1 | 1 | 3 | 1 | 43 | 11 | 0 | 0 | 5 | |
| 14 | 15 | 14 | 23 | 29 | 22 | 21 | 38 | 61 | 72 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 141 | 172 | |
| Cash & Bank | 13 | 2 | 4 | 12 | 10 | 2 | 5 | 10 | 15 | 58 |
| 58 | 61 | 77 | 86 | 103 | 87 | 124 | 162 | 53 | 70 | |
| Total Assets | 120 | 110 | 130 | 159 | 187 | 199 | 226 | 350 | 504 | 658 |
| Total Debt | 19 | 6 | 9 | 5 | 1 | 12 | 18 | 50 | 158 | 180 |
| Net Working Capital | 15 | 21 | 34 | 58 | 66 | 104 | 102 | 64 | 72 | 136 |
| Contingent Liabilities | 14 | 18 | 21 | 22 | 26 | 31 | 23 | 27 | 22 | 51 |
| Book Value per Share | 98.95 | 111.14 | 127.14 | 164.07 | 206.27 | 250.34 | 287.16 | 315.63 | 338.96 | 479.79 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | -2 | 6 | 20 | 14 | 24 | -1 | 22 | -5 | -27 | |
| Cash from Investing | 0 | -2 | -8 | -9 | -13 | -43 | -7 | -78 | -105 | -137 |
| Cash from Financing | 0 | -8 | 4 | -4 | -3 | 10 | 9 | 61 | 110 | 156 |
| 0 | -11 | 2 | 7 | -1 | -8 | 2 | 4 | 1 | -8 | |
| Free Cash Flow | 0 | -2 | -2 | 13 | -0 | 19 | -28 | -59 | -105 | -100 |
| OCF / Net Profit | 0.00 | -0.31 | 0.70 | 0.96 | 0.60 | 1.20 | -0.05 | 1.38 | -0.45 | 0.62 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 28 | 2 | -55 | -174 | -274 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | ||||||||||
| EPS (₹) | 11.26 | 12.03 | 15.91 | 37.08 | 42.14 | 35.59 | 36.46 | 28.40 | 24.94 | -18.32 |
| Book Value (₹) | 98.95 | 111.14 | 127.14 | 164.07 | 206.27 | 250.34 | 287.16 | 315.63 | 338.96 | 479.79 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.75 | 1.00 | 1.00 |
| Cash EPS (₹) | 18.60 | 22.14 | 25.64 | 47.78 | 52.40 | 45.98 | 47.57 | 37.40 | 33.57 | -12.12 |
| PROFITABILITY | ||||||||||
| Operating Margin % | 11.47% | 11.94% | 13.93% | 18.94% | 17.33% | 14.34% | 14.88% | 14.69% | 10.32% | 0.79% |
| Net Margin % | 4.92% | 5.81% | 6.58% | 9.68% | 10.58% | 8.59% | 8.64% | 7.21% | 4.01% | -12.80% |
| ROE % | 11.38% | 11.45% | 13.35% | 25.47% | 22.76% | 15.53% | 13.46% | 9.03% | 5.54% | -16.55% |
| ROCE % | 14.23% | 11.47% | 18.10% | 39.30% | 30.83% | 20.24% | 17.18% | 12.57% | 7.74% | -4.85% |
| 5.37% | 5.99% | 7.61% | 14.71% | 13.94% | 10.52% | 9.80% | 5.45% | 2.46% | -7.52% | |
| EFFICIENCY | ||||||||||
| Debtor Days | 123 | 135 | 135 | 102 | 115 | 114 | 107 | 156 | 177 | 167 |
| Inventory Days | 39 | 45 | 39 | 31 | 41 | 40 | 33 | 49 | 69 | 71 |
| Payable Days | 171 | 174 | 130 | 76 | 91 | 93 | 67 | 100 | 128 | 131 |
| -9 | 6 | 44 | 57 | 64 | 60 | 73 | 105 | 118 | 107 | |
| FINANCIAL HEALTH | ||||||||||
| Debt to Equity (x) | 0.34x | 0.10x | 0.12x | 0.05x | 0.01x | 0.09x | 0.11x | 0.27x | 0.80x | 0.55x |
| Interest Coverage (x) | 7.29x | 9.26x | 14.60x | 40.77x | 38.93x | 36.44x | 22.35x | 10.07x | 5.66x | -1.62x |
| 1.27x | 1.50x | 1.60x | 1.95x | 2.00x | 3.39x | 3.46x | 1.54x | 1.38x | 1.59x | |
| GROWTH | ||||||||||
| Revenue Growth % | 0.00% | -10.20% | 22.55% | 60.75% | 3.93% | -10.31% | 3.60% | 2.81% | 19.83% | 30.31% |
| Operating Profit Growth % | 0.00% | -5.72% | 36.18% | 115.44% | -4.92% | -14.22% | 5.67% | -10.65% | -0.83% | -54.91% |
| Net Profit Growth % | 0.00% | 6.83% | 32.23% | 133.08% | 13.63% | -15.85% | 2.44% | -24.49% | -33.09% | -515.39% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -12.16% | -173.44% | |
| VALUATION | ||||||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 44.99x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.31x | 2.06x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.09% | 0.10% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 25.07x | 56.08x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for BPLPHARMA
Loading news…
🤖
AI Stock Analyst
Bharat Parenterals Ltd.
🔒
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account